SUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION. Supplement to: All-Cause Mortality Reductions from. Measles Catch-Up Campaigns in Africa

Similar documents
Global reductions in measles mortality and the risk of measles resurgence

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

IMMUNIZATION VACCINES & EMERGENCIES

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

Update on Progress and Challenges in Achieving Measles and Rubella Targets

AIDS in Africa. An Update. Basil Reekie

Measles Mortality Reduction and Pre- Elimination in the African Region,

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

Scaling Up Nutrition Action for Africa

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

TT Procured by UNICEF

What is this document and who is it for?

Africa s slow fertility transition

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Effect of National Immunizations Days on Immunization Coverage, Child Morbidity and Mortality: Evidence from Regression Discontinuity Design

Update from GAVI Aurelia Nguyen

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Comparative Analyses of Adolescent Nutrition Indicators

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Overview of WHO/UNICEF Immunization Coverage Estimates

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

Progress Towards the Child Mortality MDG in Urban Sub-Saharan Africa. Nyovani Janet Madise University of Southampton

DHS COMPARATIVE REPORTS 32

Annex 2 A. Regional profile: West Africa

Performance of National Measles Case-Based Surveillance Systems in The WHO African Region

Supplemental Digital Content

Supplementary Figures

Global Measles and Rubella Update. April 2018

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Ageing and mental health resources for older persons in the African region of the World Health Organization

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Common EQA Mistakes - A provider Perspective. Experience from East African Regional External Quality Assessment Scheme (EA-REQAS)

Changes in proximate determinants of fertility in sub-saharan Africa

Progress has been made with respect to health conditions.

Ouagadougou Declaration

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

IMMUNIZATION VACCINE DEVELOPMENT

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Prioritizing Emergency Polio Eradication Activities

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

Aboubacar Kampo Chief of Health UNICEF Nigeria

Health situation analysis in the African Region. Basic indicators 2006

Age-Sex Structure for Selected African countries in the early 2000s

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

Yellow fever Vaccine investment strategy

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Global Measles and Rubella Update November 2018

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

IMMUNIZATION VACCINE DEVELOPMENT

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Update on Meningococcal A Vaccine Development and Introduction

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

511,000 (57% new cases) ~50,000 ~30,000

Objectives of Rotavirus Surveillance

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Using routine data to estimate numbers of women with female genital mutilation / cutting in European countries

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

UNAIDS 2013 AIDS by the numbers

The Millennium Development Goals Report. asdf. Gender Chart UNITED NATIONS. Photo: Quoc Nguyen/ UNDP Picture This

AFRICA. The continent of All challenges

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

Children in Africa. Key statistics on child survival, protection and development

Global Measles and Rubella Update October 2018

Introduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region Lessons Learnt

Fertility and Family Planning in Africa: Call for Greater Equity Consciousness

HPV Vaccine Lessons Learned & New Ways Forward

Value of post-licensure data to assess public health value Example of rotavirus vaccines

Expert Group Meeting on the Regional Report for the African Gender and Development Index

TFI Proceedings, Recommendations and implications for 2005

Urbanicity, Poverty and the Double Burden of Malnutrition in Low and Middle Income Countries 1,2,3

Rotavirus Vaccine Impact and Effectiveness in Armenia and Moldova

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

CEO Board report Seth Berkley MD CEO

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

Status of Outbreak Vulnerable Countries

CDER EDITORIAL Through this issue of the

February Health Impact Report 2010

EBOLA SITUATION REPORT

VPD in Mediterranean Basin and Black Sea: the Polio case

Influenza Surveillance In the WHO African Region

Spectrum. Quick Start Tutorial

40 years of childhood vaccination programmes in Africa. Mind the gap

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Transcription:

SUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION Supplement to: All-Cause Mortality Reductions from Measles Catch-Up Campaigns in Africa (by Ariel BenYishay and Keith Kranker) 1

APPENDIX A: DATA DHS survey data. We collected data on child deaths across Africa from the Demographic and Health Surveys (DHS). We combined data from multiple DHS surveys for 25 countries (listed in Table A1) that met the two following criteria: 1. The country had a Measles Initiative (MI) campaign. 2. At least one DHS survey round was fielded after the first MI campaign. The surveys ask each mother (respondent) for the dates of birth for each of her children (a birth history ).In addition, for each birth, they ask the mother whether the child is still alive; if the child is not alive, the surveys ask the child s age at the time of the child s death (or the date the child died). These birth histories were used to construct a child-level data file with 893,524 observations using 52 surveys conducted in 1997 or later (see Table I in the paper). This approach excludes anyone born before January 1991 (539,533 people). The process is straightforward because the DHS files have the same variable names and coding schemes (with some exceptions). Variation in the campaign timing entails samples for each country spanning different time periods. For example, our baseline sample includes children born in Tanzania (the country with the earliest campaign) in 1996, whereas most countries in the sample do not include children born before 1997. Similarly, the timing of the last DHS round determines the youngest child we observe in each country for a full 60 months. Figure 1 in the paper demonstrates this variation. Figure A1 demonstrates geographic variation in the dates of the SIAs. We then reshaped this file into a panel data file with one observation for each month for each child s first 60 months or until the date of the interview (whichever occurred first). The reshaped data have 42,434,559 observations (47.5 months per child, on average). We also collapsed the panel data into cohort-month cells that aggregated data by cohort children born in 2

the same sub-national region in the same month. Regression models with this cohort-level information were similar to the panel data regressions and yielded qualitatively similar findings. The DHS surveys have a complex sampling frame. Unless otherwise noted, we use in all analyses the weights provided in the survey to calculate point estimates and standard errors. However, we adjust survey weights in instances in which we have more than one survey per country. Although there was only one survey round at a time in each country, the birth histories overlap (some cohorts are covered by multiple surveys). Thus, we sum all instances in which country-birth month cohorts were included in a survey sample and divide the DHS weight by this sum (i.e., for cohorts included in only one survey wave, the DHS weight is divided by one; for those included in two waves, the DHS weights are divided by two). We thus avoid overweighting cohorts based on overlapping surveys. Dates in the Ethiopia surveys were converted from the Ethiopian calendar to the Gregorian calendar by shifting dates by seven years, eight months. Merging with MI campaign data. In addition to the DHS survey data, we used campaign dates and geographic information available on the Measles Initiative website in January 2010 (http://www.measlesinitiative.org/) and, in some cases, provided by American Red Cross staff. There were nationwide campaigns in 18 of the 25 countries in our sample. The remaining 7 countries were covered by 2 or more regional campaigns (17 regional campaigns total). The campaigns occurred between September 2001 and December 2007, although most were between 2001 and 2004. Although we refer to countries in the text for ease of exposition, sub-national regions with different campaign dates were always treated separately (for example, when creating country fixed effects or trends or when clustering standard errors). 3

Table A1 lists the dates of each county s campaign (that is, each SIA). It also provides the routine measles vaccination rate from 2000 (reported by the World Bank Indicators), and estimates of the number of children vaccinated and the percentage of the target population vaccinated (estimated by MI staff). When merging the two data sets, we could merge the campaign dates using country or region indicators (in some cases, after reconciling region names using publicly available information and maps). In a few cases, the data could not be merged. For the Democratic Republic of the Congo, three regions (North Kivu and the two Kasai regions) were covered in campaigns prior to 2005. We know the remaining regions were covered in a series of campaigns in 2004 2006, but we were not able to determine the specific dates of the campaigns; we excluded these 23,377 observations. We excluded 3,274 observations from two geographic areas in Cameroon s first DHS round (CM3) that were combined into macroregions and could not be matched to campaign dates. We excluded any data that could not be matched to a campaign date in this survey. For Nigeria, cannot be merged to the correct campaign date because the North- Central and South-Central regions are called Central in the first DHS survey (NG3), ; therefore, 2,250 observations were dropped. 4

Table A1: Measles routine vaccination rates, Measles Initiative SIAs, SIA coverage rates, and DHS surveys Dec-02, Number of observations in DHS d Measles routine Date of SIA b Unweighted Weighted Country vaccination rate, 2000 a National SIA Regional SIA(s) Num. of children vaccinated b Campaign vaccination rate b,c Date of DHS survey(s) d N Pct Pct. Benin 70% Dec-01, Jan-03 950,780; 2,299,583 106%, 105% Nov-06, Nov-01, Aug-96 40,218 7.42 6.88 Burkina Faso 48% Dec-01 4,943,115 96% Dec-03, Mar-99 20,326 3.75 3.92 Cameroon b 49% Jan-02, Dec-02 2,789,542; 4,570,817 93%, 90% Sep-04, Jul-98 14,143 2.61 3.01 Congo (Brazzaville) 34% Oct-04 1,356,625 78% Nov-05 7,273 1.34 1.89 Congo Democratic 46% 5,554,824; 96%, Sep-07 11,205 2.07 3.20 Republic e Oct-05, Nov-06, Dec-06 6,957,653; 6,966,200 89%, 97%, 96% Ethiopia 33% Nov-02, Jan-03, May-05 2,277,988; 5,101,007; 7,422,074 76%, 98%, 91% Aug-05, Jun-00 28,141 5.19 5.52 Ghana 90% Dec-01, Dec-02 790,798; 12,595,255 99%, 102% Nov-08, Nov-03, Feb-99 15,135 2.79 1.98 Guinea 42% Nov-03 3,202,848 98% Jun-05, Aug-99 14,900 2.75 2.82 Kenya 78% Jun-02 13,302,991 98% Mar-09, Sep-03, Jul-98 25,881 4.77 3.75 Lesotho 74% Apr-03 178,522 87% Jan-10, Feb-05 15,410 2.84 2.34 Madagascar 57% Sep-04 7,546,229 99% Jul-09, Jun-04, Dec-97 35,541 6.55 6.20 Malawi 73% Aug-02 1,906,985 120% Feb-05, Nov-00 29,743 5.49 4.89 Mali 49% Dec-01 4,998,491 99% Dec-06, Jun-01, May-96 43,844 8.09 7.44 Namibia 69% Jun-03 318,240 94% Mar-07, Dec-00 14,015 2.58 2.50 Niger 37% Dec-04 5,071,149 99% Jun-06, Jul-98 16,742 3.09 4.34 Nigeria e 33% Dec-05, Jun-06 28,538,974; 26,353,793 95%, 83% Nov-08, Aug-03, May-99 59,370 10.95 10.91 Rwanda 74% Feb-03 3,082,583 101% Apr-08, Aug-05, Nov-00 34,995 6.45 4.08 São Tomé and Principe 69% Dec-07 64,487 101% Jan-09 2,987 0.55 0.72 Senegal 48% Jan-03 4,854,077 98% Jun-05 19,802 3.65 4.85 Sierra Leone 37% Nov-03 2,404,882 93% Jun-08 13,133 2.42 3.49 Swaziland 92% Jun-02 127,829 81% Mar-07 5,755 1.06 1.47 Tanzania 78% Sep-01 3,687,390 104% Feb-05, Nov-96 15,601 2.88 3.71 Uganda 57% Nov-01 13,457,127 116% Oct-06, Mar-01 24,101 4.45 4.28 Zambia 85% Oct-02, Jun-03 729,469; 4,955,647 112%, 108% Oct-07, Jun-02, Jan-97 21,419 3.95 3.46 Zimbabwe 75% Jul-02 1,537,263 85% Apr-06, Dec-99 12,518 2.31 2.37 a First dose measles immunization coverage rate among 12- to 23-month-old children. Source: World Development Indicators catalog, WHO and UNICEF (http://www.who.int/immunization_monitoring/routine/en). b Source: MI publications, correspondence with MI staff, and MI administrative data. c Vaccination rate is calculated as the number of children reached divided by the target population (typically all children aged 9 months-15 years) calculated by MI staff. In some cases, coverage rate can be greater than 100% where target population estimates were inaccurate or vaccination of children outside target age ranges took place. d Source: Tabulations with DHS data. The reported date of DHS surveys is the last interview date in the survey data. e One or more regions were excluded from the data because it was unclear when the SIA occurred in the regions. 5

Figure A1: Map of countries with Measles Initiative SIA and DHS surveys Notes: Countries listed in Appendix Table A1 are shaded by the date of the national SIA or first regional SIA.

APPENDIX B: BENCHMARK COMPARISON OF RESULTS The model by Wolfson et al. (2007) uses the data set most comparable to our study s because it comprises data from 1999 through 2005. It estimates the number of age-specific cases in each country by (1) multiplying the number of cases by a notational efficiency ratio in countries with better surveillance systems, or (2) simply assuming that all unvaccinated children are infected. It then multiplies the number of cases by country- and age-specific case-fatality ratios from Stein et al. (2003), which ranged from 2% to 6%. Markov simulations are used to estimate confidence intervals. This approach is known as a natural history model. As Table B1 shows, the study estimates that Africa s measles mortality rate fell from 19.4% of nonvaccinated children to 4.8%, which we interpret as roughly a (2.91-1.44 = ) 1.47 percentage point change in all-cause mortality. Using data from 2000 through 2010 and a more sophisticated (but similar) state-space model, Simons et al. (2012) estimate the number of worldwide measles deaths somewhat lower than that estimated by Wolfson et al. (2007). Simons et al. (2012) estimate that 187,000 deaths were averted by the SIAs in Africa in 1999 about two-thirds of Wolfson et al. s (2007) estimate for 1999. The back-of-the-envelope implied change in the Africa-wide measles mortality rate (Table B1, row 6) is also lower in the study by Simons et al. (2012, Table B1, final columns). Note that our estimates of the effect of the SIAs on measles mortality is an estimate of the average effect across the children in the countries in our study. To compare our estimates (2.4 percentage points in the child-level model and 3.0 percentage points in the panel data model) to Table B1, our estimates can be multiplied by the fraction of African children in countries with an SIA (in each respective year).

Table B1: Benchmark Comparison Wolfson et al. (2007) Simons et al. (2012) 1999 2005 2000 2012 1. Births (millions) a 26.9 29.9 27.4 32.7 2. Routine MCV coverage 50% 65% 56% 76% 3. Number of measles deaths (95% CI) 4. Measles mortality rate (deaths per year / 100 live births per year) b 506,000 (370,000-658,000) 126,000 (93,000-164,000) 337,000 (216,600-653,000) 186,675 (8,900-258,100) 1.88 0.42 1.23 0.57 5. Number of deaths averted 387,000 871,000 197,900 569,300 6. Implied change in all-cause mortality rate (deaths per year / 100 live births per year) c 1.44 2.91 0.72 1.74 Source: Wolfson et al. (2007) Tables 1 and 2 and Simons et al. (2012) table unless otherwise noted. a Total population times the crude birth rate, from the World Development Indicators (http://data.worldbank.org, September 2012). b Row (3) divided by row (1) times 100. c Row (5) divided by row (1) times 100.

REFERENCES Simons E, Ferrari M, Fricks J, Wannemuehler K, Anand A, Burton A, Strebel P. 2012. Assessment of the 2010 Global Measles Mortality Reduction Goal: Results from a Model of Surveillance Data. The Lancet 6736(12): 60522 4. Stein C, Birmingham M, Kurian M, Duclos P, Strebel P. 2003. The Global Burden of Measles in the Year 2000: A Model That Uses Country-Specific Indicators. Journal of Infectious Diseases 187(Suppl.1): S8 S14. Wolfson L, Strebel P, Gacic-Dobo M, Hoekstra E, McFarland J, Hersh B. 2007. Has the 2005 Measles Mortality Reduction Goal Been Achieved? A Natural History Modelling Study. The Lancet 369: 191 200. doi:10.1016/s0140-6736(07)60107-x.